Ipsen Company
Ipsen is a global specialty-driven biopharmaceutical company focused on innovation and specialty care.
Funding Status:
IPO
Industry:
End-to-End Drug Development
Estimated Revenue:
$500M to $1B
Technology:
Biotechnology, Pharmaceutical, Product Research
Acquisitions Number:
9
Number Of Exists:
5
Headquarters:
Boulogne-billancourt, Ile-de-France, France
Total Funding:
22000000.0
Last Funding Date:
2017-11-20
Last Funding Type:
Post-IPO Equity
Investor Type:
Undisclosed
Employee Number:
1001-5000
Investment Stage:
N/A
Founded Date:
1929-01-01